Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations. Capsules are a common oral solid dosage form and are produced in a variety of shapes, ...

Formulation characteristics must be optimized, following device selection, to achieve the desired performance for the capsule loaded in the dry powder inhaler. Capsules used in dry powder inhalers ...

A more tamper-proof formulation of extended-release Oxycodone DETERx (Collegium Pharmaceutical Inc) could help to minimize abuse of the opioid drug. Topline results of a new study show that crushing ...

Cyclosporine has revolutionised the transplantation scene in the last 20 years by helping with immunosuppresion. Novartis have so far had the patent Cyclosporine has revolutionised the transplantation ...

In the Phase 2a obesity study, GSBR-1290 demonstrated a clinically meaningful and statistically significant placebo-adjusted mean decrease in weight of 6.2% 1 (p<0.0001) at 12 weeks. At Week 12, 67% ...

New York, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Softgel capsules have been crafted using gelatin as the primary raw material. However, substantial investments in research and development, coupled with ...

Introduction: Different oral sustained-release (SR) formulations of tramadol have been introduced in pain treatment in order to prolong the dosage interval to improve convenience for the patient. The ...

(MENAFN- GlobeNewsWire - Nasdaq) The softgel capsules market offers growth via rising demand for plant-based options, tech advancements, and regulatory changes. Sustainability, bioavailability, and ...

The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules for over-the-counter treatment of frequent heartburn., according to a company press ...

Florida Supplement Company Publishes Educational Resource Examining Green Tea, Berberine, Apple Cider Vinegar, Chromium, Cinnamon, and Ginger Formulations-Compares DIY Recipes to Measured-Dose Capsule ...

Nuplazid, a non-dopaminergic, selective serotonin inverse agonist, targets 5-HT2A receptors that are thought to be involved in Parkinson's disease psychosis. Acadia announced that the Food and Drug ...